• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Pfizer’s Acquisition of Hospira Boosts Healthcare ETFS

    Written by Charlotte McLeod
    |
    Feb. 06, 2015 04:45PM PST

    ETF Trends reported that healthcare ETFs enjoyed some gains on Thursday after Pfizer Inc. (NYSE:PFE) announced that it plans to acquire Hospira Inc. (NYSE:HSP) for $17 billion.

    ETF Trends reported that healthcare ETFs enjoyed some gains on Thursday after Pfizer Inc. (NYSE:PFE) announced that it plans to acquire Hospira Inc. (NYSE:HSP) for $17 billion.

    As quoted in the market news:

    Pfizer is the second-largest holding in the Health Care Select Sector SPDR (NYSEArca: XLV), the largest health care ETF, while Hospira is a smaller holding in the fund. Together, the two stocks entered Thursday with a combined weight of 8% in XLV. The $12.7 billion XLV tracks the S&P Health Care Select Sector Index.

    That is the same index the the Direxion Daily Healthcare Bull 3x Shares (NYSEArca: CURE) attempts to deliver three times the daily returns of, so what is good for XLV is even better for CURE. And things have going quite well for CURE.

    Click here to read the full ETF Trends report.

    The Conversation (0)

    Go Deeper

    AI Powered
    Blank pill bottle spilling a variety of pharmaceutical pills and capsules.

    5 Biggest Pharmaceutical ETFs for Investors in 2026

    Collage with hands holding shiny DNA molecule on blue background.

    5 Biggest Biotechnology ETFs in 2026

    Latest News

    BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026 

    Appendix 4C Cashflow Statementand Quarterly Activities Report

    Lexaria Celebrates its 70th Patent Award

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES